Ignite Creation Date:
2024-05-06 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05128773
Status:
TERMINATED
Last Update Posted:
2023-06-22
First Post:
2021-11-10
Brief Title:
Study of Amcenestrant SAR439859 Versus Tamoxifen for Patients With Hormone Receptor-positive HR Early Breast Cancer Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity
Sponsor:
Sanofi
Organization:
Sanofi
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-13
Completion Date Type:
ACTUAL
First Submit Date:
2021-11-10
First Submit QC Date:
November 10 2021
Study First Post Date:
2021-11-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-06-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-15
Last Update Post Date:
2023-06-22
Last Update Post Date Type:
ACTUAL